chr20-3910728-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PP2PP5BP4BS1_Supporting

The NM_001386393.1(PANK2):​c.803A>G​(p.Asp268Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D268Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

PANK2
NM_001386393.1 missense

Scores

5
5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:2

Conservation

PhyloP100: 2.09

Publications

15 publications found
Variant links:
Genes affected
PANK2 (HGNC:15894): (pantothenate kinase 2) This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]
PANK2 Gene-Disease associations (from GenCC):
  • pantothenate kinase-associated neurodegeneration
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 41 curated pathogenic missense variants (we use a threshold of 10). The gene has 11 curated benign missense variants. Gene score misZ: 0.17856 (below the threshold of 3.09). Trascript score misZ: -0.052065 (below the threshold of 3.09). GenCC associations: The gene is linked to pantothenate kinase-associated neurodegeneration.
PP5
Variant 20-3910728-A-G is Pathogenic according to our data. Variant chr20-3910728-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 225428.We mark this variant Likely_pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BP4
Computational evidence support a benign effect (MetaRNN=0.08382577). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000788 (12/152296) while in subpopulation EAS AF = 0.00212 (11/5192). AF 95% confidence interval is 0.00119. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PANK2NM_001386393.1 linkc.803A>G p.Asp268Gly missense_variant Exon 3 of 7 ENST00000610179.7 NP_001373322.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PANK2ENST00000610179.7 linkc.803A>G p.Asp268Gly missense_variant Exon 3 of 7 1 NM_001386393.1 ENSP00000477429.2 Q9BZ23-4

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152178
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00211
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000231
AC:
58
AN:
251334
AF XY:
0.000221
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00310
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000431
AC:
63
AN:
1461862
Hom.:
0
Cov.:
32
AF XY:
0.0000495
AC XY:
36
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00154
AC:
61
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1112002
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152296
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41580
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000534
Hom.:
0
Bravo
AF:
0.000125
ExAC
AF:
0.000264
AC:
32
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pigmentary pallidal degeneration Pathogenic:4Uncertain:1
Mar 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 378 of the PANK2 protein (p.Asp378Gly). This variant is present in population databases (rs562740927, gnomAD 0.3%). This missense change has been observed in individual(s) with pantothenate kinase-associated neurodegeneration (PMID: 15747360, 20193558, 26828213). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Asp268Gly. ClinVar contains an entry for this variant (Variation ID: 225428). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PANK2 protein function. For these reasons, this variant has been classified as Pathogenic. -

-
Juno Genomics, Hangzhou Juno Genomics, Inc
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM2_Supporting+PP3+PM3_Strong -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:reference population

- -

Mar 24, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 16, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PANK2 c.1133A>G (p.Asp378Gly) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.00023 in 251536 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in PANK2 causing Pantothenate Kinase-Associated Neurodegeneration (0.00023 vs 0.0011), allowing no conclusion about variant significance. c.1133A>G has been reported in combination with another pathogenic variant in the literature in individuals affected with Pantothenate Kinase-Associated Neurodegeneration (Zhang_2005, Wu_2009, Mak_2011, Lim_2011, Kim_2012, Pan_2020, Yang_2022) and this variant is commonly affected alleles in Chinese origin (Zhang_2005, Wu_2009, Ma_2014, Ma_208, Pan_2020). The following publications have been ascertained in the context of this evaluation (PMID: 22547525, 24868354, 22103354, 24689511, 29801903, 21198414, 32310012, 20076801, 19224615, 35246191, 15747360, 30681573). ClinVar contains an entry for this variant (Variation ID: 225428). Based on the evidence outlined above, the variant was classified as pathogenic. -

not provided Uncertain:1
Dec 11, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported previously in multiple patients who had a variety of symptoms including dystonia, tremors, eye of the tiger sign, and a clinical diagnosis of atypical PKAN (PMID: 15747360, 29801903, 30681573, 19224615, 26828213, 20076801, 35246191, 35462688, 37139068, 24868354, 37453004); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21198414, 15747360, 32310012, 1301187, 33396642, 29962256, 20193558, 31540697, 24348190, 35180557, Choi2020[article], 35246191, 29801903, 30681573, 19224615, 26828213, 20076801, 37139068, 35462688, 24868354, 37453004) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Pathogenic
0.16
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.93
.;D;.;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.020
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.97
.;D;D;D
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.084
T;T;T;T
MetaSVM
Pathogenic
1.3
D
MutationAssessor
Benign
1.9
.;L;.;.
PhyloP100
2.1
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-4.0
D;D;.;.
REVEL
Pathogenic
0.69
Sift
Benign
0.17
T;D;.;.
Sift4G
Benign
0.090
T;T;T;T
Polyphen
0.025
.;B;.;.
Vest4
0.54
MutPred
0.77
.;Loss of stability (P = 0.0131);.;.;
MVP
0.94
MPC
0.67
ClinPred
0.14
T
GERP RS
4.5
Varity_R
0.72
gMVP
0.72
Mutation Taster
=7/93
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs562740927; hg19: chr20-3891375; API